Summit Therapeutics
SMMT
#1668
Rank
A$18.56 B
Marketcap
A$23.22
Share price
-1.84%
Change (1 day)
-17.56%
Change (1 year)

Summit Therapeutics (SMMT) - Net assets

Net assets on the balance sheet as of June 2026 : A$0.91 Billion

According to Summit Therapeutics 's latest financial reports the company has A$0.91 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Summit Therapeutics - Net assets on balance sheet (from 2020 to 2020)

Net assets by year

Year Net assets Change
2023-12-31$A$0.11 B-38.73%
2022-12-31$A$0.18 B62.01%
2021-12-31$A$0.11 B11.18%
2020-12-31$A$0.10 B
2019-01-31$A$0.10 B-1393.89%
2018-01-31$-A$7.8 Million8.07%
2017-01-31$-A$7.22 Million-115.66%
2016-01-31$A$46.05 M21.3%
2015-01-31$A$37.96 M157.69%
2014-01-31$A$14.73 M115.78%
2013-01-31$A$6.82 M21.79%
2012-01-31$A$5.6 M-39.92%
2011-01-31$A$9.33 M-60.91%
2010-01-31$A$23.87 M-10.93%
2009-01-31$A$26.8 M-77.71%
2008-01-31$A$0.12 B18.41%
2007-01-31$A$0.10 B82.94%
2006-01-31$A$55.5 M-13.96%
2005-01-31$A$64.51 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sarepta Therapeutics
SRPT
A$2.21 B 142.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
A$0.32 B-64.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
A$88.11 M-90.34%๐Ÿ‡บ๐Ÿ‡ธ USA